Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002306720 | SCV002602750 | likely pathogenic | Congenital amegakaryocytic thrombocytopenia | 2022-01-28 | criteria provided, single submitter | clinical testing | NM_005373.2(MPL):c.56delA(N19Tfs*20) is expected to be pathogenic in the context of congenital amegakaryocytic thrombocytopenia. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in MPL, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |